[1] FACAL F,ARROJO M,PAZ E,et al . Association between psychiatric hospitalizations of patients with schizophrenia and polygenic risk scores based on genes with altered expression by antipsychotics[J].Acta Psychiatr Scand,2022,146(2):139-150. [2] MARDER S R,MEEHAN S R,CATHERINE W,et al. Effects of brexpiprazole across symptom domains in patients with schizophrenia:post hoc analysis of short-and long-term studies[J].Schizophr Bull Open,2021,2(1):14. [3] 赵明勇.支持性心理治疗联合丙戊酸纳在精神分裂症治疗中的价值[J].重庆医学,2019,48(24):4176-4178. [4] AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and statistical manualof mental disordler.fourth edition.text revision ( DSM-IV-TR)[M]. Washington,DC:American Psychiatric Publishing,2000:312-313. [5] HOPKINS S C,OGIRALA A,LOEBEL A,et al . Transformed PANSS factors intended to reduce pseudospecificity among symptom domains and enhance understanding of symptom change in antipsychotic-treated patients with schizophrenia[J].Schizophr Bull,2018,44(3):593-602. [6] 舒畅,王高华,王惠玲,等.精神分裂症症状与威斯康星卡片分类测验成绩的相关性[J].中国心理卫生杂志,2004,18(8):580-582. [7] 汪达山,陈建华,杜亚利,等.中华成人智力量表与韦氏成人智力量表中国修订版的相关研究[J].中国神经精神疾病杂志,2007,33(1):31-34. [8] 齐安思,陆峥.多巴胺与精神分裂症药物治疗机制研究进展[J].中华精神科杂志,2019,52(4):289-292. [9] 周绍宇,冯振晓,姚晓萍,等.典型与非典型抗精神病药对精神分裂症患者认知症状的影响[J].上海交通大学学报(医学版),2020,40(8):1075-1080. [10] 陈旭,梁世桥,冯媛,等.鲁拉西酮与利培酮对中国精神分裂症患者催乳素水平影响的比较[J].中国新药与临床杂志,2021,40(12):839-843. [11] 邱允,马亚荣,佘生林,等.两阶段认知行为治疗对精神分裂症住院患者的影响[J].临床精神医学杂志,2020,30(5):308.
2023, Vol. 40 
